Targeting phosphoglycerate dehydrogenase in multiple myeloma

BACKGROUND: Multiple myeloma (MM) is a hematological malignancy characterized by the clonal expansion of plasma cells in the bone marrow. To date, this disease is still incurable and novel therapeutic approaches are required. Phosphoglycerate dehydrogenase (PHGDH) is the first and rate-limiting enzy...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsaadi, Samah, Steiro, Ida, Abdollahi, Pegah, Vandsemb, Esten N., Yang, Rui, Slørdahl, Tobias S., Rø, Torstein Baade, Menu, Eline, Sponaas, Anne-Marit, Børset, Magne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784327/
https://www.ncbi.nlm.nih.gov/pubmed/33397437
http://dx.doi.org/10.1186/s40164-020-00196-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784327/
https://www.ncbi.nlm.nih.gov/pubmed/33397437
http://dx.doi.org/10.1186/s40164-020-00196-w

Ejemplares similares